These studies reported that vimentin expression appeared to be associated with poor prognosis in node-negative ductal breast carcinomas, and that vimentin was preferentially expressed in human breast carcinomas with low levels of estrogen receptors. The gene discussed is ESR1; the disease is breast carcinoma.